These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 10489659)
1. Sertraline in stroke-associated lability of mood. Burns A; Russell E; Stratton-Powell H; Tyrell P; O'Neill P; Baldwin R Int J Geriatr Psychiatry; 1999 Aug; 14(8):681-5. PubMed ID: 10489659 [TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. Murray V; von Arbin M; Bartfai A; Berggren AL; Landtblom AM; Lundmark J; Näsman P; Olsson JE; Samuelsson M; Terént A; Varelius R; Asberg M; Mårtensson B J Clin Psychiatry; 2005 Jun; 66(6):708-16. PubMed ID: 15960563 [TBL] [Abstract][Full Text] [Related]
3. Preventing depression after stroke: Results from a randomized placebo-controlled trial. Almeida OP; Waterreus A; Hankey GJ J Clin Psychiatry; 2006 Jul; 67(7):1104-9. PubMed ID: 16889454 [TBL] [Abstract][Full Text] [Related]
4. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial. Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916 [TBL] [Abstract][Full Text] [Related]
5. Sertraline and cognitive behavioral therapy for depressed alcoholics: results of a placebo-controlled trial. Moak DH; Anton RF; Latham PK; Voronin KE; Waid RL; Durazo-Arvizu R J Clin Psychopharmacol; 2003 Dec; 23(6):553-62. PubMed ID: 14624185 [TBL] [Abstract][Full Text] [Related]
6. Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms. Spalletta G; Caltagirone C Funct Neurol; 2003; 18(4):227-32. PubMed ID: 15055748 [TBL] [Abstract][Full Text] [Related]
7. Emotional incontinence--the other poststroke phenomenon. Bharathi V; Lee FS Med J Malaysia; 2006 Oct; 61(4):490-2. PubMed ID: 17243530 [TBL] [Abstract][Full Text] [Related]
8. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K; Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242 [TBL] [Abstract][Full Text] [Related]
9. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics. Roy A Biol Psychiatry; 1998 Oct; 44(7):633-7. PubMed ID: 9787889 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia. Mulholland C; Lynch G; King DJ; Cooper SJ J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747 [TBL] [Abstract][Full Text] [Related]
11. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression. Ravindran AV; Guelfi JD; Lane RM; Cassano GB J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Sertraline in Patients With Major Depressive Disorder Naive to Selective Serotonin Reuptake Inhibitors: A 10-Week Randomized, Multicenter, Placebo-Controlled, Double-Blind, Academic Clinical Trial. Valle-Cabrera R; Mendoza-Rodríguez Y; Robaina-García M; Ballesteros J; Cordero-Jiménez JR; Espinosa-Rodríguez NB; Sotolongo-Garcia Y; Lauria-Horner B; J Clin Psychopharmacol; 2018 Oct; 38(5):454-459. PubMed ID: 30106883 [TBL] [Abstract][Full Text] [Related]
13. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. Tan VP; Cheung TK; Wong WM; Pang R; Wong BC World J Gastroenterol; 2012 Nov; 18(42):6127-33. PubMed ID: 23155342 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. Lydiard RB; Stahl SM; Hertzman M; Harrison WM J Clin Psychiatry; 1997 Nov; 58(11):484-91. PubMed ID: 9413414 [TBL] [Abstract][Full Text] [Related]
16. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Cooper-Kazaz R; Apter JT; Cohen R; Karagichev L; Muhammed-Moussa S; Grupper D; Drori T; Newman ME; Sackeim HA; Glaser B; Lerer B Arch Gen Psychiatry; 2007 Jun; 64(6):679-88. PubMed ID: 17548749 [TBL] [Abstract][Full Text] [Related]
17. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Van Ameringen MA; Lane RM; Walker JR; Bowen RC; Chokka PR; Goldner EM; Johnston DG; Lavallee YJ; Nandy S; Pecknold JC; Hadrava V; Swinson RP Am J Psychiatry; 2001 Feb; 158(2):275-81. PubMed ID: 11156811 [TBL] [Abstract][Full Text] [Related]
18. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Stahl SM Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227 [TBL] [Abstract][Full Text] [Related]
19. Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial. Lin CH; Wang SH; Lane HY Int J Neuropsychopharmacol; 2022 Aug; 25(7):545-555. PubMed ID: 35023557 [TBL] [Abstract][Full Text] [Related]
20. Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Ventura D; Armstrong EP; Skrepnek GH; Haim Erder M Curr Med Res Opin; 2007 Feb; 23(2):245-50. PubMed ID: 17288677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]